Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy.
Olah C, Shmorhun O, Klamminger GG, Rawitzer J, Sichward L, Hadaschik B, Al-Nader M, Krafft U, Niedworok C, Váradi M, Nyirady P, Kiss A, Szekely E, Reis H, Szarvas T.
Olah C, et al. Among authors: kiss a.
J Pathol Clin Res. 2025 Jan;11(1):e70017. doi: 10.1002/2056-4538.70017.
J Pathol Clin Res. 2025.
PMID: 39817402
Free PMC article.